Heba Nowyhed

Heba Nowyhed, Ph.D.
is a Senior Associate at Vida Ventures.
She has over 14 years of experience in Immunobiology, and 3+ years of combined experience working with the business development group at LJI and with the OCR office at Yale.
She received her Ph.D.
at Yale University where she focused on identifying key drivers of autoimmunity across various disease settings.
She completed her Postdoctoral Fellowship in the Inflammation Department at the La Jolla Institute for Allergy and Immunology in late 2015.
There she studied T cell biology and investigated the intrinsic mechanisms that drive the development of T cell lineages in models of acute infection, as well as atherosclerosis, IBD, and other chronic inflammatory settings.
Early 2016, Heba joined the research team at Kite Pharma as a Scientist where she played a key role generating the pre-clinical data packages for two IND filings.
She went on to lead a pipeline program as a Senior Scientist that resulted in three additional IND filings.
As an Associate Director, she successfully established key cross functional collaborations, developed and lead an Assay and Automation group, as well as lead a team developing next-generation products for Kite’s solid tumor programs.